Radiopharm Theranostics Receives FDA IND Approval for Phase 2b Imaging Trial in Brain Metastases Biotech Investing
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys